In addition, Aguilar-Morante et al. [79] showed that CCAAT/enhancer-binding protein β (C/EBPβ) suppression substantially decreased the levels of S100A4 in glioblastoma cells, resulting in inhibitions to growth, transformation capacity, and migration. This evidence concerns the gene S100A4 and glioblastoma.